Literature DB >> 19829056

Prospective surveillance of varicella-zoster virus infections in an out-patient setting in Switzerland.

Andrea Iseli1, Christoph Aebi, Kurt Banz, Matthias Brunner, André M Schmutz, Ulrich Heininger.   

Abstract

Limited data are available on the clinical impact of varicella in the ambulatory setting. Our goal was to determine real-life data on the clinical outcomes, medical management, and resource utilization in patients with varicella in Switzerland, a country without a universal immunization program against varicella. A total of 236 patients (222 = 94 % primarily healthy individuals) with a clinical diagnosis of varicella were recruited by pediatricians and general practitioners. Age range of patients was 0 - 47 years with a median of 5 years. The great majority of patients (179 = 76 %) were <or=6 years of age. 134 (57%) patients were single cases and in the remaining 102 patients a total of 112 further cases of varicella occurred in their households. Of these, 17 (15%) were primary cases, 18 (16%) were co-primary cases, 75 (67%) were secondary cases, and 2 cases (2%) were not directly linked to the index case. A total of 29 complications were observed in 26 (11%) of 236 patients, none of them with a known underlying disease and all subsided without apparent sequelae. All complications occurred in children under 12 years of age. In conclusion, this study describes the spectrum of varicella in an out-patient setting with a sizeable rate of complications and raises the question of the value of prophylactic immunization.

Entities:  

Mesh:

Year:  2009        PMID: 19829056     DOI: 10.4161/hv.9897

Source DB:  PubMed          Journal:  Hum Vaccin        ISSN: 1554-8600


  5 in total

1.  Safety and immunogenicity of single dose live attenuated varicella vaccine (VR 795 Oka strain) in healthy Indian children: a randomized controlled study.

Authors:  Monjori Mitra; Mma Faridi; Apurba Ghosh; Nitin Shah; Raju Shah; Suparna Chaterjee; Manish Narang; Nisha Bhattacharya; Gandhali Bhat; Harish Choudhury; Ganesh Kadhe; Amey Mane; Sucheta Roy
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Economic burden of varicella in children 1-12 Years of age in Hungary, 2011-2015.

Authors:  Z Meszner; Z Molnar; E Rampakakis; H K Yang; B J Kuter; Lara J Wolfson
Journal:  BMC Infect Dis       Date:  2017-07-14       Impact factor: 3.090

3.  Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization.

Authors:  Margarita Riera-Montes; Kaatje Bollaerts; Ulrich Heininger; Niel Hens; Giovanni Gabutti; Angel Gil; Bayad Nozad; Grazina Mirinaviciute; Elmira Flem; Audrey Souverain; Thomas Verstraeten; Susanne Hartwig
Journal:  BMC Infect Dis       Date:  2017-05-18       Impact factor: 3.090

4.  Trends in Varicella Burden of Disease Following Introduction of Routine Childhood Varicella Vaccination in Argentina: A 12-Year Time Series Analysis.

Authors:  Norberto Giglio; Pieralessandro Lasalvia; Manjiri Pawaskar; Cintia I Parellada; Yaneth Gil Rojas; Paula Micone; Virginia V Babic; Silvina E Neyro
Journal:  Vaccines (Basel)       Date:  2022-07-20

5.  Varicella in Poland: economic burden in children 1-12 years of age in Poland, 2010-2015.

Authors:  Jacek Wysocki; Ilona Malecka; Joanna Stryczynska-Kazubska; Emmanouil Rampakakis; Barbara Kuter; Lara J Wolfson
Journal:  BMC Public Health       Date:  2018-03-27       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.